Effect of Group Led Creative Writing on Mood in Cancer Patients
NCT ID: NCT03536702
Last Updated: 2020-10-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2018-03-28
2018-11-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer
NCT02339870
Expressive Writing and Adjustment to Metastatic Breast Cancer
NCT00624156
Health Benefits of Expressive Writing: Study One
NCT03546673
Emotion Regulation and Cancer Caregiving
NCT06123416
Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study
NCT02575898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Creative Writing Workshop
The intervention arm will receive a dedicated workshop for one and a half hours every 2 weeks for 3 months.
Creative Writing Workshop
This group will participate in a writing workshop in group sessions.
Independent Writing - Control Group
The control arm will receive a book (i.e., Writing Down Bones by Natalie Goldberg) on creative writing and asked to read and do writing activities for one and a half hours once every two weeks for 3 months.
Independent Writing - Control Group
This group will receive a book for a self writing session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Creative Writing Workshop
This group will participate in a writing workshop in group sessions.
Independent Writing - Control Group
This group will receive a book for a self writing session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Milton S. Hershey Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Monika Joshi
Assistant Professor, Department of Medicine, Division of Hematology-Oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Monika Joshi, MD
Role: PRINCIPAL_INVESTIGATOR
Penn State Hershey Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penn State Cancer Institute
Hershey, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
DOI: 10.1200/JCO.2017.35.31_suppl.178 Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 178-178.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSCI 18-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.